Janssen Pharmaceuticals, Inc. Joins Global Movement to Reduce Leading Cause of Preventable Cardiovascular Death on World Thrombosis Day
The World Thrombosis Day campaign is excited to announce its newest global partner, Janssen Pharmaceuticals, Inc., a company driven by its vision to help restore the joy and simplicity of life for patients by advancing cardiovascular and metabolic care. Janssen has the unique ability to collaborate, innovate, and inspire millions of people impacted by the epidemics of cardiovascular and metabolic disease. Janssen’s sponsorship of World Thrombosis Day supports the mobilization of more than 300 partner organizations across 65 countries delivering awareness-driven initiatives to reduce death and disability from thrombosis – the underlying cause of heart attack, stroke and venous thromboembolism (VTE).
Observed on October 13, World Thrombosis Day is an annual event led by the International Society on Thrombosis and Haemostasis (ISTH) and carried out by hundreds of organizations worldwide. The focus for World Thrombosis Day this year is VTE and increased risk due to hospitalization. Up to 60 percent of all VTEs occur during or after hospitalization and VTE is the leading preventable cause of hospital death.